Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes (Q45348074)
Jump to navigation
Jump to search
scientific article published on 17 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes |
scientific article published on 17 February 2013 |
Statements
1 reference
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes (English)
1 reference
T Heise
1 reference
E Seewaldt-Becker
1 reference
S Macha
1 reference
S Hantel
1 reference
S Pinnetti
1 reference
L Seman
1 reference
H J Woerle
1 reference
17 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference